BI Asset Management Fondsmaeglerselskab’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.8M | Buy |
696,017
+289,540
| +71% | +$7.57M | 0.13% | 132 |
|
|
2026
Q1 | $11.4M | Buy |
406,477
+139,984
| +53% | +$3.73M | 0.12% | 139 |
|
|
2025
Q4 | $6.64M | Sell |
266,493
-33,113
| -11% | -$835K | 0.06% | 213 |
|
|
2025
Q3 | $7.63M | Sell |
299,606
-514,481
| -63% | -$12.7M | 0.07% | 206 |
|
|
2025
Q2 | $19.7M | Buy |
814,087
+94,448
| +13% | +$2.2M | 0.19% | 113 |
|
|
2025
Q1 | $18.2M | Sell |
719,639
-282,617
| -28% | -$7.4M | 0.21% | 111 |
|
|
2024
Q4 | $26.6M | Sell |
1,002,256
-110,627
| -10% | -$3M | 0.28% | 77 |
|
|
2024
Q3 | $32.2M | Buy |
1,112,883
+226,294
| +26% | +$6.6M | 0.56% | 45 |
|
|
2024
Q2 | $24.8M | Sell |
886,589
-31,881
| -3% | -$878K | 0.41% | 63 |
|
|
2024
Q1 | $25.5M | Sell |
918,470
-5,602
| -0.6% | -$155K | 0.48% | 56 |
|
|
2023
Q4 | $26.6M | Buy |
924,072
+528,745
| +134% | +$16M | 0.57% | 45 |
|
|
2023
Q3 | $13.1M | Buy |
395,327
+28,525
| +8% | +$1.01M | 0.3% | 86 |
|
|
2023
Q2 | $13.5M | Buy |
366,802
+42,007
| +13% | +$1.64M | 0.32% | 78 |
|
|
2023
Q1 | $13.3M | Sell |
324,795
-7,065
| -2% | -$305K | 0.35% | 78 |
|
|
2022
Q4 | $17M | Buy |
331,860
+76,412
| +30% | +$3.66M | 0.45% | 65 |
|
|
2022
Q3 | $11.2M | Buy |
255,448
+145,749
| +133% | +$7.08M | 0.57% | 49 |
|
|
2022
Q2 | $5.75M | Buy |
109,699
+5,663
| +5% | +$289K | 0.25% | 85 |
|
|
2022
Q1 | $5.39M | Sell |
104,036
-3,510
| -3% | -$182K | 0.21% | 98 |
|
|
2021
Q4 | $6.35M | Sell |
107,546
-58,419
| -35% | -$2.89M | 0.23% | 92 |
|
|
2021
Q3 | $7.14M | Buy |
165,965
+43,332
| +35% | +$1.92M | 0.27% | 95 |
|
|
2021
Q2 | $4.8M | Buy |
122,633
+59,083
| +93% | +$2.3M | 0.18% | 118 |
|
|
2021
Q1 | $2.3M | Buy |
63,550
+9,222
| +17% | +$327K | 0.09% | 168 |
|
|
2020
Q4 | $2M | Sell |
54,328
-768,434
| -93% | -$28.2M | 0.09% | 154 |
|
|
2020
Q3 | $28.6M | Sell |
822,762
-27,925
| -3% | -$979K | 1.3% | 20 |
|
|
2020
Q2 | $26.4M | Sell |
850,687
-120,733
| -12% | -$4.1M | 1.35% | 20 |
|
|
2020
Q1 | $30.1M | Sell |
971,420
-823
| -0.1% | -$28K | 1.79% | 11 |
|
|
2019
Q4 | $36.1M | Buy |
972,243
+35,448
| +4% | +$1.26M | 1.71% | 14 |
|
|
2019
Q3 | $31.9M | Buy |
936,795
+145,540
| +18% | +$5.29M | 1.57% | 20 |
|
|
2019
Q2 | $32.5M | Sell |
791,255
-45,482
| -5% | -$1.81M | 1.55% | 23 |
|
|
2019
Q1 | $33.7M | Buy |
836,737
+206,656
| +33% | +$8.28M | 1.7% | 13 |
|
|
2018
Q4 | $26.1M | Buy |
630,081
+49,749
| +9% | +$2.07M | 1.67% | 12 |
|
|
2018
Q3 | $24.3M | Buy |
580,332
+24,874
| +4% | +$958K | 1.51% | 22 |
|
|
2018
Q2 | $19.1M | Buy |
555,458
+6,956
| +1% | +$238K | 1.37% | 24 |
|
|
2018
Q1 | $18.5M | Sell |
548,502
-8,432
| -2% | -$290K | 1.43% | 24 |
|
|
2017
Q4 | $19.1M | Buy |
556,934
+95,914
| +21% | +$3.27M | 1.43% | 23 |
|
|
2017
Q3 | $15.6M | Sell |
461,020
-21,607
| -4% | -$694K | 1.17% | 26 |
|
|
2017
Q2 | $15.4M | Buy |
482,627
+32,674
| +7% | +$1.03M | 1.15% | 24 |
|
|
2017
Q1 | $14.6M | Hold |
449,953
| – | – | 1.05% | 30 |
|
|
2016
Q4 | $13.9M | Buy |
449,953
+83,266
| +23% | +$2.54M | 1.09% | 25 |
|
|
2016
Q3 | $11.8M | Buy |
366,687
+21,080
| +6% | +$705K | 0.99% | 32 |
|
|
2016
Q2 | $11.5M | Sell |
345,607
-60,183
| -15% | -$1.92M | 1.07% | 36 |
|
|
2016
Q1 | $11.4M | Buy |
405,790
+26,350
| +7% | +$753K | 0.86% | 30 |
|
|
2015
Q4 | $11.6M | Buy |
+379,440
| New | +$11.9M | 0.92% | 29 |
|
Other funds holding PFE
BI Asset Management Fondsmaeglerselskab's PFE Position: Q2 2026 in Review
BI Asset Management Fondsmaeglerselskab increased its Pfizer (PFE) stake by 71% in Q2 2026, buying an estimated $7.57M and bringing the position to 696,017 shares worth $16.8M. The position accounts for 0.13% of the portfolio, ranked #132.
BI Asset Management Fondsmaeglerselskab first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $36.1M in Q4 2019. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab held 696,017 shares of Pfizer worth $16.8M as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab bought 289,540 Pfizer shares in Q2 2026, an estimated $7.57M.
- Pfizer made up 0.13% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #132 holding.
- BI Asset Management Fondsmaeglerselskab first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
- BI Asset Management Fondsmaeglerselskab's Pfizer position peaked at $36.1M in Q4 2019.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.